Pieris soars on $31M-plus checkpoint development deal; Luca Santarelli takes helm at Therachon
• Boston-based Pieris $PIRS has inked a deal to work with France’s Servier on some bispecific checkpoint development programs. The deal comes with a $31 million upfront and $338 million in milestones for their progress on PRS-332 plus up to $201 million in milestones for each of four other programs in the package. The deal covers five bispecific therapeutic programs, led by Pieris’ PRS-332 program. Pieris shares shot up 27% on the news.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
